Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults with Systemic Lupus Erythematosus

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/20 → 1/1/23

Funding

  • Eli Lilly and Company / Nektar Therapeutics